Impact of body mass index on incidence of febrile neutropenia and treatment‐related mortality in United States veterans with diffuse large B‐cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2014-12, Vol.167 (5), p.699-702
Hauptverfasser:	Ganti, Arun, Liu, Weijian, Luo, Suhong, Sanfilippo, Kristen M., Roop, Ryan, Lynch, Ryan, Riedell, Peter, O'Brian, Katiuscia, Colditz, Graham A., Carson, Kenneth R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Murine-Derived - administration & dosage Antibodies, Monoclonal, Murine-Derived - adverse effects Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Body Mass Index Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects diffuse large B‐cell lymphoma Doxorubicin - administration & dosage Doxorubicin - adverse effects empiric dose‐reduction Febrile Neutropenia - chemically induced Febrile Neutropenia - drug therapy Febrile Neutropenia - mortality Female Humans Incidence Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Male Middle Aged non‐Hodgkin lymphoma obesity Prednisone - administration & dosage Prednisone - adverse effects Retrospective Studies treatment‐related toxicity United States - epidemiology Veterans Vincristine - administration & dosage Vincristine - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!